ARS Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RUBRIC CAPITAL MANAGEMENT LP | 02/13/2026 | 6.20 M | $72.23 M | 37.78% | 6.27% |
| BLACKROCK, INC. | 02/12/2026 | 5.09 M | $59.24 B | 5.26% | 5.15% |
| SR ONE CAPITAL MANAGEMENT, LP | 02/12/2026 | 4.01 M | $46.75 M | 0.00% | 4.06% |
| ABRDN PLC | 01/16/2026 | 3.56 M | $41.43 M | 14.82% | 3.60% |
| VANGUARD GROUP INC | 01/29/2026 | 3.51 M | $40.88 M | 0.25% | 3.55% |
| STATE STREET CORP | 02/13/2026 | 3.22 M | $37.55 M | 11.34% | 3.26% |
| FRANKLIN RESOURCES INC | 02/11/2026 | 2.54 M | $29.63 M | 6.05% | 2.57% |
| UBS GROUP AG | 01/29/2026 | 2.21 M | $25.76 B | 235.04% | 2.24% |
| CITADEL ADVISORS LLC | 02/17/2026 | 1.95 M | $22.77 M | 23.23% | 1.98% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 1.55 M | $18.09 M | 3.14% | 1.57% |
| JANNEY MONTGOMERY SCOTT LLC | 02/11/2026 | 1.29 M | $15.00 M | 6.17% | 1.30% |
| BAMCO INC /NY/ | 02/17/2026 | 1.27 M | $14.78 M | 0.00% | 1.28% |
| GOLDMAN SACHS GROUP INC | 02/10/2026 | 812.04 K | $9.46 M | -38.75% | 0.82% |
| LEVIN CAPITAL STRATEGIES, L.P. | 01/30/2026 | 747.51 K | $8.71 M | -2.20% | 0.76% |
| BANK OF MONTREAL /CAN/ | 02/12/2026 | 643.41 K | $7.50 M | 100.00% | 0.65% |
| CENTERBOOK PARTNERS LP | 02/11/2026 | 568.36 K | $6.62 M | 10.93% | 0.58% |
| RAYMOND JAMES FINANCIAL INC | 02/18/2026 | 566.06 K | $6.59 M | -25.16% | 0.57% |
| MORGAN STANLEY | 02/13/2026 | 552.36 K | $6.44 M | -21.14% | 0.56% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 550.93 K | $6.42 M | 5.79% | 0.56% |
| JPMORGAN CHASE & CO | 02/11/2026 | 417.09 K | $4.86 M | 1,089.68% | 0.42% |
| LISANTI CAPITAL GROWTH, LLC | 02/09/2026 | 396.51 K | $4.62 M | 87.75% | 0.40% |
| EMPIRE LIFE INVESTMENTS INC. | 02/04/2026 | 352.60 K | $4.11 M | -0.87% | 0.36% |
| INVESTMENT MANAGEMENT ASSOCIATES INC /ADV | 02/03/2026 | 311.50 K | $3.63 M | 100.00% | 0.32% |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/13/2026 | 304.45 K | $3.55 M | -9.16% | 0.31% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 226.80 K | $2.64 M | -12.87% | 0.23% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 02/12/2026 | 216.30 K | $2.52 B | 47.45% | 0.22% |
| ROYCE & ASSOCIATES LP | 02/09/2026 | 207.05 K | $2.41 M | 100.00% | 0.21% |
| BARCLAYS PLC | 02/13/2026 | 196.39 K | $2.29 M | -14.08% | 0.20% |
| DAFNA CAPITAL MANAGEMENT LLC | 02/17/2026 | 190.07 K | $2.21 M | 35.28% | 0.19% |
| K2 PRINCIPAL FUND, L.P. | 02/13/2026 | 181.10 K | $2.11 M | 186.55% | 0.18% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 176.12 K | $2.05 M | -1.14% | 0.18% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 163.01 K | $1.90 M | 5.43% | 0.17% |
| NUVEEN, LLC | 02/12/2026 | 149.60 K | $1.74 B | 0.00% | 0.15% |
| KNIGHTS OF COLUMBUS ASSET ADVISORS LLC | 02/09/2026 | 130.73 K | $1.52 M | -2.79% | 0.13% |
| PRINCIPAL FINANCIAL GROUP INC | 02/02/2026 | 112.77 K | $1.31 M | 46.67% | 0.11% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 111.70 K | $1.30 M | -60.86% | 0.11% |
| LEGATO CAPITAL MANAGEMENT LLC | 02/06/2026 | 109.10 K | $1.27 M | 176.82% | 0.11% |
| SWISS NATIONAL BANK | 02/12/2026 | 107.20 K | $1.25 M | 27.16% | 0.11% |
| SIT INVESTMENT ASSOCIATES INC | 02/12/2026 | 92.88 K | $1.08 M | 24.62% | 0.09% |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 02/05/2026 | 87.16 K | $1.02 M | 0.00% | 0.09% |
| VALLEY FORGE INVESTMENT CONSULTANTS INC ADV | 02/12/2026 | 83.23 K | $969.57 K | 0.00% | 0.08% |
| ALPS ADVISORS INC | 02/12/2026 | 81.17 K | $945.61 K | 63.65% | 0.08% |
| MARSHALL WACE, LLP | 02/13/2026 | 79.21 K | $922.84 K | -59.86% | 0.08% |
| SG AMERICAS SECURITIES, LLC | 01/09/2026 | 76.20 K | $888.00 K | 654.11% | 0.08% |
| ASSUREDPARTNERS INVESTMENT ADVISORS, LLC | 02/03/2026 | 75.78 K | $882.83 K | 31.14% | 0.08% |
| SEI INVESTMENTS CO | 02/13/2026 | 74.81 K | $871.50 K | 55.49% | 0.08% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 74.26 K | $865.08 K | 0.56% | 0.08% |
| RHUMBLINE ADVISERS | 02/13/2026 | 73.29 K | $853.85 K | -9.74% | 0.07% |
| CITADEL ADVISORS LLC | 02/17/2026 | 69.60 K | $810.84 K | -45.75% | 0.07% |
| HRT FINANCIAL LP | 02/12/2026 | 68.65 K | $799.00 K | 100.00% | 0.07% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
ARS Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 176 institutional investors and hedge funds held shares of ARS Pharmaceuticals Inc. The most heavily invested institutionals were:
Rubric Capital Management LP: 6.2 M
BlackRock, Inc.: 5.09 M
SR ONE CAPITAL MANAGEMENT, LP: 4.01 M
abrdn plc: 3.56 M
VANGUARD GROUP INC: 3.51 M
STATE STREET CORP: 3.22 M
49.86% of ARS Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 50.89 M shares in the last 24 months. This purchase volume represents approximately $479.87 M in transactions.